This Article Full Text Full Text (PDF) All Versions of this Article: 42/5/932    most recent 01.HYP.0000092883.16529.84v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smallegange, C. Articles by Adams, M. A. Search for Related Content PubMed PubMed Citation Articles by Smallegange, C. Articles by Adams, M. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ENALAPRIL MALEATE SODIUM Medline Plus Health Information High Blood Pressure Kidney Transplantation Related Collections Cardio-renal physiology/pathophysiology Cardiovascular Pharmacology ACE/Angiotension receptors Animal models of human disease Hypertension - basic studies

(Hypertension. 2003;42:932.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Transplantation of Enalapril-Treated Kidneys Confers Persistent Lowering of Arterial Pressure in SHR

From the Department of Pharmacology and Toxicology, Queen’s University (C.S., M.A.A.), Kingston, and the Department of Physiology, University of Western Ontario (R.L.K.), London, Ontario, Canada.

Correspondence to Dr Michael A. Adams, Department of Pharmacology and Toxicology, Queen’s University, Kingston, Ontario, Canada K7L 3N6. E-mail adams{at}post.queensu.ca

The kidney plays a critical role in regulating the level of arterial pressure and in the pathogenesis of hypertension. Important evidence has come from studies in which hypertension is generated by transplanting kidneys from genetically hypertensive rats into normotensive recipients, suggesting that the level of blood pressure is strongly influenced by the genetic background of the kidney. We hypothesized that pharmacotherapy could modify specific properties intrinsic to the kidney such that after transplantation, there would be persistent changes in the level of arterial pressure. We determined that angiotensin-converting enzyme inhibitor treatment (enalapril) in spontaneously hypertensive rats induced both a persistent 17% reduction of mean arterial pressure and a persistent change in the kidney. This persistent change in the circulation could be completely transferred to untreated spontaneously hypertensive rats by kidney transplantation; ie, mean arterial pressure in untreated spontaneously hypertensive rat recipients was persistently lowered after transplantation of a kidney from a previously treated spontaneously hypertensive rat donor. In addition, the persistent lowering of mean arterial pressure after enalapril treatment could be completely abolished by implanting an untreated kidney, thereby revealing the importance of the kidney-specific changes. Furthermore, after within-group transplantations, there were no changes in the level of arterial pressure; ie, a 16% difference in mean arterial pressure remained between the 2 groups. The findings revealed that drug-induced changes specific to the kidney determined the level of arterial pressure, thereby suggesting the kidney should be a key therapeutic target for pharmacotherapy.

Key Words: transplantation, renal • renin-angiotensin system • rats, spontaneously hypertensive • arterial pressure • angiotensin-converting enzyme inhibitors

This article has been cited by other articles:

				T. Schluter, A. C. Steinbach, A. Steffen, R. Rettig, and O. Grisk Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition Cardiovasc Res, July 17, 2008; (2008) cvn185v2. [Abstract] [Full Text] [PDF]

				S. L. Bourque, M. Komolova, K. Nakatsu, and M. A. Adams Long-Term Circulatory Consequences of Perinatal Iron Deficiency in Male Wistar Rats Hypertension, January 1, 2008; 51(1): 154 - 159. [Abstract] [Full Text] [PDF]

				K. Skov, H. Eiskjaer, H. E. Hansen, J. K. Madsen, S. Kvist, and M. J. Mulvany Treatment of Young Subjects at High Familial Risk of Future Hypertension With an Angiotensin-Receptor Blocker Hypertension, July 1, 2007; 50(1): 89 - 95. [Abstract] [Full Text] [PDF]

				T. Schluter, R. Grimm, A. Steinbach, G. Lorenz, R. Rettig, and O. Grisk Neonatal sympathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R391 - R399. [Abstract] [Full Text] [PDF]

				R. Rettig and O. Grisk The Kidney as a Determinant of Genetic Hypertension: Evidence From Renal Transplantation Studies Hypertension, September 1, 2005; 46(3): 463 - 468. [Full Text] [PDF]

				O. Grisk Sympatho-renal interactions in the determination of arterial pressure: role in hypertension Exp Physiol, March 1, 2005; 90(2): 183 - 187. [Abstract] [Full Text] [PDF]

				C. Smallegange, T. M. Hale, T. L. Bushfield, and M. A. Adams Persistent Lowering of Pressure by Transplanting Kidneys From Adult Spontaneously Hypertensive Rats Treated With Brief Antihypertensive Therapy Hypertension, July 1, 2004; 44(1): 89 - 94. [Abstract] [Full Text] [PDF]